# Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects

> **NCT02682901** · PHASE4 · COMPLETED · sponsor: **Eastern Virginia Medical School** · enrollment: 84 (actual)

## Conditions studied

- Diabetic Autonomic Neuropathy

## Interventions

- **DRUG:** Cycloset
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT02682901
- **Lead sponsor:** Eastern Virginia Medical School
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2015-10-05
- **Primary completion:** 2018-11-15
- **Final completion:** 2018-11-15
- **Target enrollment:** 84 (ACTUAL)
- **Last updated:** 2021-12-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02682901

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02682901, "Bromocriptine-QR Therapy on Sympathetic Tone and Vascular Biology in Type 2 Diabetes Subjects". Retrieved via AI Analytics 2026-06-03 from https://api.ai-analytics.org/clinical/NCT02682901. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*